Nicotine: Clinical Trials

30 trials of Nicotine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 4 terminated, 2 active not recruiting, 1 not yet recruiting. 30 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 330Completed 22, Terminated 4, Active not recruiting 2, Not yet recruiting 1, Unknown 1
Phase 23Completed 2, Terminated 1

Follow Nicotine: new trials by email Literature Review of Nicotine trials Research Report on Nicotine

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
iCanQuit Smoking Cessation Among Hispanic Adults
iCanQuit Smartphone App Smoking Cessation Program, Nicotine Gum, Nicotine Patch - Cigarette Smoking-Related Carcinoma
Phase 3Not yet recruitingFred Hutchinson Cancer Center8542026-12-012026-10-29
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3CompletedRose Research Center, LLC1502024-08-292026-02-06
Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT
Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction
Phase 3TerminatedRose Research Center, LLC42023-12-272025-03-30
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
Nicoderm CQ 21Mg/24Hr Transdermal System - Tobacco Use Cessation
Phase 2 / Phase 3CompletedBrown University492021-09-012025-04-06
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2
Phase 3CompletedAssistance Publique - Hôpitaux de Paris322020-12-092022-02-11
Optimizing Tobacco Use Treatment for PLWHA
Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence
Phase 3Active not recruitingAbramson Cancer Center at Penn Medicine3402020-02-172026-09-04
Individualizing Pharmacotherapy for African American Smokers
Nicotine patch, Varenicline Tartrate, Bupropion - Smoking Cessation
Phase 3CompletedUniversity of Kansas Medical Center3922019-05-012023-04-03
Vaping THC From Electronic Cigarettes
Nicotine, Cannabis, PAX Loose Leaf Vaporizer - Marijuana Dependence
Phase 3CompletedUniversity of California, San Francisco82019-03-202023-06-29
Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.
Electronic cigarette without nicotine (ECwN) plus active varenicline tablets, Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline, Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline - Smoking Cessation, Smoking, Cigarette
Phase 3Active not recruitingAssistance Publique - Hôpitaux de Paris6502018-10-172025-12-29
Effects of Exercise and Nicotine on Cognition in Smokers
Nicotine, Moderate Intensity Exercise - Smoking Cessation
Phase 3CompletedWestern University, Canada342017-05-012024-05-03
The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation
Nicotine patch, e-cigarette, Nicotine - Smoking Cessation
Phase 3CompletedUniversity of Auckland, New Zealand11242016-03-012021-08-19
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence
Phase 2 / Phase 3TerminatedCentre for Addiction and Mental Health182015-07-012018-07-19
The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
Nicotine Replacement Therapy (NRT), Varenicline, HIV Tailored Quit Smoking Counseling - HIV, Smoking Cessation
Phase 3UnknownOttawa Hospital Research Institute2562014-01-012015-12-14
CPT and Smoking Cessation
Cognitive Processing Therapy (CPT), Bupropion, nicotine replacement therapy (NRT) - Stress Disorders, Post-Traumatic, Smoking
Phase 2 / Phase 3CompletedVA Office of Research and Development692013-12-112018-09-11
Nicotine Mouth Film for Craving Relief.
Nicotine - Smoking Cessation
Phase 3CompletedGlaxoSmithKline3202012-09-012014-01-30
A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline
Telephone counseling, Nicotine patches, Incentive - Smoking Cessation
Phase 3CompletedUniversity of California, San Diego38162012-06-012020-02-13
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University2822011-07-012017-11-14
Concurrent Bupropion / Varenicline for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University7022011-03-012014-08-06
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
Placebo, Nicotine - Tobacco Dependence
Phase 3TerminatedMcNeil Consumer Healthcare Division of McNEIL-PPC, Inc.2572011-03-012012-04-23
Pharmacogenetics of Nicotine Addiction Treatment
Varenicline, Placebo, Transdermal Nicotine - Nicotine Addiction
Phase 3CompletedUniversity of Pennsylvania12462010-12-012016-03-03

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Smoking Cessation (20)  ·  Tobacco Use Disorder (11)  ·  Smoking (8)  ·  Cigarette Smoking (4)  ·  Tobacco Use Cessation (4)  ·  Vaping (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Harm Reduction (2)  ·  Lung Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  COVID-19 (1)  ·  Marijuana Abuse (1)  ·  Motor Activity (1)  ·  Small Cell Lung Carcinoma (1)  ·  Stress Disorders, Post-Traumatic (1)

Sponsors

University of California, San Diego (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Duke University (2)  ·  GlaxoSmithKline (2)  ·  Rose Research Center, LLC (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Brown University (1)  ·  Centre for Addiction and Mental Health (1)  ·  Fred Hutchinson Cancer Center (1)  ·  McNeil AB (1)  ·  McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  Ottawa Hospital Research Institute (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (22)  ·  Canada (5)  ·  France (2)  ·  Czechia (1)  ·  New Zealand (1)  ·  Puerto Rico (1)

Top investigators

Shu-Hong Zhu, Ph.D. (3)  ·  Caryn Lerman, PhD (1)  ·  Cheryl A Oncken, MD (1)  ·  Daniel Qi, MD (1)  ·  Elisabeth Kruse, PhD (1)  ·  Ellen R. Gritz, PhD (1)  ·  Eric A Dedert, PhD (1)  ·  F. Joseph McClernon, Ph.D. (1)  ·  Harry Prapavessis, PhD (1)  ·  James Stevenson, MD (1)  ·  Jed E Rose, Ph.D. (1)  ·  Jonathan Bricker, PhD (1)  ·  Karen Cropsey, Ph.D. (1)  ·  Laura MacPherson, PhD (1)

Results publications

PMID 34611902, PMID 37142273, PMID 24057996, PMID 24934962, PMID 25012994, PMID 25588294, PMID 25732567, PMID 29986268, PMID 30454668, PMID 30614717, PMID 30664539, PMID 30946162, PMID 31129603, PMID 31502736, PMID 31515173, PMID 33300144, PMID 33713409, PMID 35639828, PMID 36387983, PMID 36789481, PMID 37230961, PMID 37338906, PMID 38369951, PMID 39868569, PMID 39976595, PMID 40174410, PMID 40358028

NIH funding

P50DA027840 (2), 2017 (1), K24AA013736 (1), M01RR006192 (1), R01CA243914 (1), R01CA298383 (1), R01DA039264 (1), R01DA046576 (1), R21CA261233 (1), R21DA029445 (1), U01DA020830 (1)